Plant ID: NPO4368
Plant Latin Name: Magnolia officinalis
Taxonomy Genus: Magnolia
Taxonomy Family: Magnoliaceae
NCBI TaxonomyDB:
85864
Plant-of-the-World-Online:
554787-1
Antibacterial; Antiseptic; Antispasmodic; Aphrodisiac; Appetizer; Digestive; Diuretic; Emmenagogue; Expectorant; Ophthalmic; Stomachic; Tonic
South Korea; China
CNR1; CNR2; | |
TSHR; | |
GLA; ALOX15; PTPRCAP; | |
TRPV1; | |
MAPK1; | |
CA2; CA12; CA9; CA3; CA4; | |
PPARA; PPARD; | |
RXRA; | |
ALOX5; XDH; | |
CASP1; CASP7; | |
TLR2; | |
HIF1A; | |
ABCB1; | |
LMNA; RAB9A; FABP3; FABP5; FABP2; FABP4; MAPT; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCB1 | P-glycoprotein 1 | P08183 | CHEMBL4302 |
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | GLA | Alpha-galactosidase A | P06280 | CHEMBL2524 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | PTPRCAP | Protein tyrosine phosphatase receptor type C-associated protein | Q14761 | CHEMBL4806 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 2 group B | RXRA | Retinoid X receptor alpha | P19793 | CHEMBL2061 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Small molecule receptor (family A GPCR) | CNR1 | Cannabinoid CB1 receptor | P21554 | CHEMBL218 |
Small molecule receptor (family A GPCR) | CNR2 | Cannabinoid CB2 receptor | P34972 | CHEMBL253 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transient receptor potential channel | TRPV1 | Vanilloid receptor | Q8NER1 | CHEMBL4794 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.253E-11 | 2.117E-07 | CA12, CA2, CA3, CA4, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.762E-09 | 5.468E-06 | CA12, CA2, CA3, CA4, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 7.886E-09 | 1.227E-05 | CA12, CA2, CA3, CA4, CA9 |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 6.705E-08 | 7.684E-05 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0008152; metabolic process | GO:0051001; negative regulation of nitric-oxide synthase activity | 1.304E-07 | 1.305E-04 | CNR1, CNR2, GLA |
BP | GO:0050896; response to stimulus | GO:0042493; response to drug | 1.318E-07 | 1.305E-04 | ABCB1, CA3, CA9, CASP1, CNR1, CNR2, FABP3, MAPK1, TLR2, TRPV1 |
BP | GO:0050896; response to stimulus | GO:0033993; response to lipid | 1.304E-06 | 7.472E-04 | CA2, CA9, CASP1, CNR1, CNR2, FABP3, PPARD, RXRA, TLR2 |
BP | GO:0050896; response to stimulus | GO:0050727; regulation of inflammatory response | 2.168E-06 | 1.152E-03 | CASP1, CNR1, CNR2, FABP4, PPARA, PPARD, TLR2 |
BP | GO:0002376; immune system process | GO:0001774; microglial cell activation | 2.507E-06 | 1.300E-03 | MAPT, TLR2, TRPV1 |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 3.048E-06 | 1.537E-03 | CASP1, HIF1A, LMNA, PPARA, PPARD, TLR2 |
BP | GO:0008152; metabolic process | GO:2000377; regulation of reactive oxygen species metabolic process | 6.829E-06 | 3.035E-03 | GLA, HIF1A, MAPT, TRPV1, XDH |
MF | GO:0060089; molecular transducer activity | GO:0004949; cannabinoid receptor activity | 7.471E-06 | 3.190E-03 | CNR1, CNR2 |
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 8.698E-06 | 3.573E-03 | CASP1, CASP7, MAPT, XDH |
BP | GO:0032501; multicellular organismal process | GO:0001816; cytokine production | 9.128E-06 | 3.681E-03 | CASP1, FABP4, HIF1A, TLR2 |
BP | GO:0008152; metabolic process | GO:0046320; regulation of fatty acid oxidation | 1.193E-05 | 4.331E-03 | CNR1, FABP3, PPARA |
BP | GO:0050896; response to stimulus | GO:0014070; response to organic cyclic compound | 1.416E-05 | 4.973E-03 | CA2, CA9, CASP1, CASP7, CNR1, MAPK1, TLR2, TRPV1 |
BP | GO:0065007; biological regulation | GO:0065009; regulation of molecular function | 1.451E-05 | 5.015E-03 | ABCB1, CASP1, CASP7, CNR1, CNR2, FABP4, GLA, HIF1A, MAPK1, MAPT, PPARA, RAB9A, TLR2, TRPV1, TSHR, XDH |
BP | GO:0009987; cellular process | GO:0038171; cannabinoid signaling pathway | 1.493E-05 | 5.019E-03 | CNR1, CNR2 |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 1.632E-05 | 5.212E-03 | ALOX15, ALOX5, TLR2 |
BP | GO:0023052; signaling | GO:0032228; regulation of synaptic transmission, GABAergic | 1.799E-05 | 5.596E-03 | CA2, CNR1, CNR2 |
BP | GO:0009987; cellular process | GO:0071345; cellular response to cytokine stimulus | 1.845E-05 | 5.657E-03 | ALOX15, CASP1, FABP4, HIF1A, MAPK1, TRPV1 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 3.168E-05 | 8.515E-03 | CA12, CA2, CA3, CA4, CA9, PPARA, PPARD, RXRA |
BP | GO:0007610; behavior | GO:0007611; learning or memory | 3.352E-05 | 8.901E-03 | CNR1, HIF1A, MAPK1, MAPT, TLR2 |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 3.724E-05 | 9.770E-03 | ALOX15, ALOX5 |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 6.559E-05 | 1.587E-02 | PPARA, PPARD, RXRA |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 1.673E-04 | 2.961E-02 | HIF1A, MAPK1, MAPT |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 2.137E-04 | 3.664E-02 | CA2, CA4, CA9, TSHR |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.048E-11 | 1.446E-09 | FABP2, FABP3, RXRA, FABP4, FABP5, PPARA, PPARD |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 3.894E-11 | 2.687E-09 | CA12, CA3, CA2, CA4, CA9 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 4.267E-06 | 1.963E-04 | ABCB1, RXRA, CA2, CYP3A4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 8.376E-05 | 2.890E-03 | CASP7, CASP1, TLR2 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 2.111E-04 | 5.827E-03 | CASP7, CASP1, MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 6.855E-04 | 1.058E-02 | ALOX5, ALOX15, MAPK1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 7.977E-04 | 1.058E-02 | ALOX5, MAPK1, TLR2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 7.977E-04 | 1.058E-02 | RXRA, MAPK1, HIF1A |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 8.438E-04 | 1.058E-02 | CNR2, CNR1, TRPV1, TSHR |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 9.197E-04 | 1.058E-02 | ALOX15, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
NA: NA | Esophagus sensitivity | NA | TRPV1; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Musculoskeletal pain | R52, G89 | TRPV1; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Chronic pathological pain | R52, G89 | TRPV1; |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Immune disorder | D80-D89 | CNR2; |
C00-D49: Neoplasms | Cutaneous T-cell lymphoma | C84.0, C84.1 | RXRA; |
K00-K95: Diseases of the digestive system | Gastroesophageal reflux disease | K21 | TRPV1; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | CNR2; TRPV1; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Cough | R05 | TRPV1; |
N00-N99: Diseases of the genitourinary system | Urinary incontinence | N39.3, N39.4, R32 | TRPV1; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | CNR2; |
K00-K95: Diseases of the digestive system | Inflammatory bowel disease | K50, K51 | CNR2; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | CNR2; TRPV1; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Acute or chronic pain | R52, G89 | TRPV1; |
G00-G99: Diseases of the nervous system G00-G99 | Acute migraine | G43 | TRPV1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoporosis | M80-M81, Z79.890 | CNR2; |
C00-D49: Neoplasms | Overactive bladder disorder | C67, N32.81 | TRPV1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
A00-B99: Certain infectious and parasitic diseases | Postherpetic neuralgia | B02.2, G44.847, G53.0 | TRPV1; |
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | CNR2; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | TRPV1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | CNR2; TRPV1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic neuropathy | E11.40 | TRPV1; |